ProQR Announces Strategic Changes to the Management Team and Key New Hires
(WorldNews Netherlands)

LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 13, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the `Company`), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases, today announced changes to its management team and key hires: Aniz Girach, MD, is joining ProQR in the role of Chief Medical Officer Tiffany Burt is joining the Company in the role of Vice president, Head of Commercial Lisa Hayes is joining the Company in the role of Vice President of Investor Relations and Corporate Communications Smital Shah is promoted to Chief Business and Financial Officer René Beukema will retire at...